London, United Kingdom
MedAccess is a social enterprise dedicated to enhancing healthcare in over 110 countries, working towards accelerating access to medical innovations. Established in 2017 and headquartered in the United Kingdom, the organization's mission is to reduce illness and mortality rates by expediting access to life-saving vaccines, medicines, diagnostics, and technologies, particularly for underserved communities.
With a $200 million capital injection from British International Investment, MedAccess operates with a team of agile global health and investment experts. Their role involves shaping agreements that dismantle the barriers obstructing access to medical innovations. As an independent and not-for-profit entity, any operating surpluses are reinvested into the development of new agreements aimed at hastening access to healthcare.
MedAccess operates within the Financial Services and Healthcare industries, demonstrating a commitment to addressing vital global health issues. As of the latest available data, the details regarding their most recent investment and investors remain undisclosed.
